期刊文献+

葡萄球菌肠毒素B突变体的构建及其抗肿瘤活性分析

Construction and Anti-Tumor Activity Analysis of Staphylococcus Enterotoxin B Mutant
下载PDF
导出
摘要 目的:通过对葡萄球菌肠毒素B(SEB)32位His进行定点突变,获得抑瘤效果显著增强的SEB突变体。方法:利用基因定点突变的方法,将SEB的32位His替换为Asn,将重组质粒转入大肠杆菌中诱导表达,用CM弱阳离子层析柱纯化获得重组蛋白,用SDS-PAGE和Western印迹对其进行鉴定,并用增殖实验检测其丝裂原活性,通过MTS法检测其体外抗肿瘤活性。结果:构建并高效表达了突变体蛋白SEB(H32N),纯化获得了足够纯度的突变体蛋白;体外实验表明,在相同浓度下,SEB(H32N)的丝裂原活性及体外抗肿瘤活性明显优于野生型SEB。结论:同野生型SEB相比,突变体蛋白SEB(H32N)对肿瘤生长的抑制作用得到了提高。 Objective: The anti-tumor activity of staphylococcal enterotoxin B(SEB) was enhanced, by substitut- ing His32 of SEB for Ash through site-directed mutagenesis. Methods: A mutant superantigen SEB(H32N) was constructed by site-directed mutagenesis, the protein was expressed in E.coli BL21 after induced, purified by CM ion-exchange chromatography and identified by SDS-PAGE and Western blot. Mitogen biological activity was ana- lyzed by cell proliferation assay in vitro, and the anti-tumor activity was analyzed using MTS method in vitro. Re- sults: The mutated protein SEB(H32N) was expressed in E.coli efficiently and purified. The results showed that at the same concentration, the mitogen biological activity and anti-tumor effect of SEB(H32N) were better than SEB on a variety of tumor cells in vitro. Conclusion: Compared with the wild type SEB, SEB(H32N) mutant ex- hibited an enhanced anti-tumor effect.
出处 《生物技术通讯》 CAS 2012年第6期772-776,共5页 Letters in Biotechnology
基金 国家科技重大专项(2009ZX09103-618)
关键词 葡糖球菌肠毒素B 突变体 表达 纯化 抗肿瘤 staphylococcus enterotoxin B mutant expression purification anti-tumor activity
  • 相关文献

参考文献13

  • 1Baker M D, Acharya K R. Superantigens: structure-function relationships[J]. Int J Med Microbiol, 2004,293(7-8):529-537.
  • 2Balaban N, Rasooly A. Staphylococcal enterotoxins[J]. Int J Food Microbiol, 2000,61:1-10.
  • 3Shimizu M, Matauzawa A, Takeda Y. A novel method for modification of tumor cells with bacterial superantigen with a heterobi-functional cross-linking agent in immunotherapy of cancer[J]. Mol Biotechnol, 2003,25(1):89-94.
  • 4Hopkins P A, Fraser J D, Pridmore A C, et al. Superantigen recognitionby HLA class Ⅱ on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin[J]. Blood, 2005,105(9):3655-3662.
  • 5Krakauer T. Immune response to staphylococcal superantigens [J]. Immunol Res, 1999,20(2):163-173.
  • 6Torres B A, Kominsky S, Perrin G Q, et al. Superantigens: the good, the bad, and the ugly[J]. Exp Biol Med, 2001,226 (3):164-176.
  • 7Schad E M, Papageorgiou A C, Svensson L A, et al. A structural and functional comparison of staphylococcalenterotoxins A and C2 reveals remarkable similarity and dissimilarity[J]. Mol Biol, 1997,269:270-280.
  • 8Lamphear J G, Bohach G A, Rich R R. Structural dichotomy of Staphylococcal enterotoxin C superantigens leading to MHCClass II-independent activation of T lymphocytes[J]. Immunology, 1998,160:2107-2114.
  • 9Holzer U, Orlikowsky T, Zehrer C, et al. T-cell stimulation- and cytokine release induced by staphylococcal enterotoxinA (SEA) and the SEAD227A mutant[J]. Immunology, 1997,90: 74-80.
  • 10Takemura S, Kudo T, Asano R, et al. A mutated superantigen SEAD227Afusion diabody specific to MUC1 and CD3 in targetedcancer immunotherapy for bile duct carcinoma[J]. Can- cer Immunol Immunother, 2002,51:33-44.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部